not-yet-known not-yet-known not-yet-known unknown Safety and Efficacy of Romiplostim in Maintaining Chemotherapy Interval and Dose Intensity in Pediatric Patients with Solid Tumors and Chemotherapy Induced Thrombocytopenia (CIT)
Background: Chemotherapy induced thrombocytopenia (CIT) is a complication of myelosuppressive chemotherapy that often results in delay or dose reduction of subsequent cycles. There are currently no FDA-approved agents for the treatment of CIT. Managem
Authors
- Suzanne Smolik (ORCID: https://orcid.org/0009-0003-2311-1707)
- Erica Tonti (ORCID: https://orcid.org/0009-0000-6439-4481)
- Zanette Kanani Bradley
- Ashley Sabus (ORCID: https://orcid.org/0000-0002-1509-931X)
Institutions
- Children's Hospital Colorado (US)
- University of Colorado Denver (US)
Publication Details
- Published
- 2025-10-03
- DOI
- https://doi.org/10.22541/au.175952200.09010617/v1
- Primary Topic
- Neutropenia and Cancer Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00